An Open Label, Two Arm, Clinical Study to evaluate the Efficacy and Safety of HQAP061801 powder as an Oral Nutritional Supplement for Occupational Work Fatigue and Post Illness Convalescence

The Himalaya Drug Company0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Both male and female adult subjects between the age group of
•2.More than 18 years to less than 60 years who are confirmed to have a history of work related fatigue as assessed through Fatigue assessment scale (FAS).
•3.Both male and female adult subjects between the age group of More than 18 years to less than 60 years who are in post illness convalescence period.
•4.Subject willing to refrain taking any other oral nutritional supplements during the study period.
•5.Subjects willing to give written informed consent
•Subjects who had not participated in similar kind of study in last 4 week.

•1.Subject with clinically significant systemic illnesses treated with medication.
•2.Subject with chronic illness which need immediate therapeutic intervention.
•3.Subjects with chronic infectious condition treated with medications
•4.Subjects who are hypersensitive to any of the ingredients,
•5.Pregnant & lactating women.

发起方